"","title","geo_accession","status","submission_date","last_update_date","type","channel_count","source_name_ch1","organism_ch1","characteristics_ch1","characteristics_ch1.1","treatment_protocol_ch1","growth_protocol_ch1","molecule_ch1","extract_protocol_ch1","label_ch1","label_protocol_ch1","taxid_ch1","hyb_protocol","scan_protocol","description","data_processing","data_processing.1","data_processing.2","platform_id","contact_name","contact_email","contact_phone","contact_department","contact_institute","contact_address","contact_city","contact_state","contact_zip/postal_code","contact_country","supplementary_file","data_row_count","cell type:ch1","donor age:ch1"
"GSM2079803","LONZA_MSC_young_1 exosome","GSM2079803","Public on May 12 2017","Mar 03 2016","May 12 2017","RNA","1","exosome","Homo sapiens","donor age: young donors (age of donor: 19 years)","cell type: BMSC","The exosomes from culture medium of BMSCs were isolated by Total Exosome Isolation Reagent (Invitrogen).","BMSCs were cultured in DMEM medium supplemented with 10% heat-inactivated fetal bovine serum at 37°C in a humidified atmosphere containing 5% CO2, and the adherent cells were collected after two or three passages for exosome isolation.","total RNA","Total RNA was isolated with the miRNeasy mini kit (Qiagen).","TaqMan probe (FAM-MGB)","A fixed volume of 3 μl of RNA solution from 50 μl of the elute was used as input in each reverse transcription (RT) reaction. An RT reaction and pre-amplification step were set up according to manufacturers’ recommendations. miRNAs were reverse transcribed using the Megaplex Primer Pools (Human Pools A v2.1) from Applied Biosystems (Bedford, MA, USA). RT reaction products from the exosome sample were further amplified using the Megaplex PreAmp Primers (Primers A v2.1).","9606","n/a","n/a","test","ath-miR-159 were used as a control. QRT-PCR was carried out on an Applied Biosystems 7900HT thermal cycler using the manufacturer’s recommended program.","All the raw data from each array was retrieved from the 7900HT and was run on Data Assist Software ver.3.1 (Applied Biosystems).","Fold Change worksheet reports test/control ratios.","GPL13987","Tomohiro,,Umezu","t_umezu@tokyo-med.ac.jp","+81-3-3342-6111","Department of Molecular Science","Tokyo Medical University","6-7-1 Nishi-shinjyuku","Shinjyuku","Tokyo","160-0023","Japan","NONE","384","BMSC","young donors (age of donor: 19 years)"
"GSM2079804","LONZA_MSC_young_2 exosome","GSM2079804","Public on May 12 2017","Mar 03 2016","May 12 2017","RNA","1","exosome","Homo sapiens","donor age: young donors (age of donor: 20 years)","cell type: BMSC","The exosomes from culture medium of BMSCs were isolated by Total Exosome Isolation Reagent (Invitrogen).","BMSCs were cultured in DMEM medium supplemented with 10% heat-inactivated fetal bovine serum at 37°C in a humidified atmosphere containing 5% CO2, and the adherent cells were collected after two or three passages for exosome isolation.","total RNA","Total RNA was isolated with the miRNeasy mini kit (Qiagen).","TaqMan probe (FAM-MGB)","A fixed volume of 3 μl of RNA solution from 50 μl of the elute was used as input in each reverse transcription (RT) reaction. An RT reaction and pre-amplification step were set up according to manufacturers’ recommendations. miRNAs were reverse transcribed using the Megaplex Primer Pools (Human Pools A v2.1) from Applied Biosystems (Bedford, MA, USA). RT reaction products from the exosome sample were further amplified using the Megaplex PreAmp Primers (Primers A v2.1).","9606","n/a","n/a","test","ath-miR-159 were used as a control. QRT-PCR was carried out on an Applied Biosystems 7900HT thermal cycler using the manufacturer’s recommended program.","All the raw data from each array was retrieved from the 7900HT and was run on Data Assist Software ver.3.1 (Applied Biosystems).","Fold Change worksheet reports test/control ratios.","GPL13987","Tomohiro,,Umezu","t_umezu@tokyo-med.ac.jp","+81-3-3342-6111","Department of Molecular Science","Tokyo Medical University","6-7-1 Nishi-shinjyuku","Shinjyuku","Tokyo","160-0023","Japan","NONE","384","BMSC","young donors (age of donor: 20 years)"
"GSM2079805","LONZA_MSC_old_1 exosome","GSM2079805","Public on May 12 2017","Mar 03 2016","May 12 2017","RNA","1","exosome","Homo sapiens","donor age: elderly donors (age of donor: 68 years)","cell type: BMSC","The exosomes from culture medium of BMSCs were isolated by Total Exosome Isolation Reagent (Invitrogen).","BMSCs were cultured in DMEM medium supplemented with 10% heat-inactivated fetal bovine serum at 37°C in a humidified atmosphere containing 5% CO2, and the adherent cells were collected after two or three passages for exosome isolation.","total RNA","Total RNA was isolated with the miRNeasy mini kit (Qiagen).","TaqMan probe (FAM-MGB)","A fixed volume of 3 μl of RNA solution from 50 μl of the elute was used as input in each reverse transcription (RT) reaction. An RT reaction and pre-amplification step were set up according to manufacturers’ recommendations. miRNAs were reverse transcribed using the Megaplex Primer Pools (Human Pools A v2.1) from Applied Biosystems (Bedford, MA, USA). RT reaction products from the exosome sample were further amplified using the Megaplex PreAmp Primers (Primers A v2.1).","9606","n/a","n/a","test","ath-miR-159 were used as a control. QRT-PCR was carried out on an Applied Biosystems 7900HT thermal cycler using the manufacturer’s recommended program.","All the raw data from each array was retrieved from the 7900HT and was run on Data Assist Software ver.3.1 (Applied Biosystems).","Fold Change worksheet reports test/control ratios.","GPL13987","Tomohiro,,Umezu","t_umezu@tokyo-med.ac.jp","+81-3-3342-6111","Department of Molecular Science","Tokyo Medical University","6-7-1 Nishi-shinjyuku","Shinjyuku","Tokyo","160-0023","Japan","NONE","384","BMSC","elderly donors (age of donor: 68 years)"
"GSM2079806","LONZA_MSC_old_2 exosome","GSM2079806","Public on May 12 2017","Mar 03 2016","May 12 2017","RNA","1","exosome","Homo sapiens","donor age: elderly donors (age of donor: 72 years)","cell type: BMSC","The exosomes from culture medium of BMSCs were isolated by Total Exosome Isolation Reagent (Invitrogen).","BMSCs were cultured in DMEM medium supplemented with 10% heat-inactivated fetal bovine serum at 37°C in a humidified atmosphere containing 5% CO2, and the adherent cells were collected after two or three passages for exosome isolation.","total RNA","Total RNA was isolated with the miRNeasy mini kit (Qiagen).","TaqMan probe (FAM-MGB)","A fixed volume of 3 μl of RNA solution from 50 μl of the elute was used as input in each reverse transcription (RT) reaction. An RT reaction and pre-amplification step were set up according to manufacturers’ recommendations. miRNAs were reverse transcribed using the Megaplex Primer Pools (Human Pools A v2.1) from Applied Biosystems (Bedford, MA, USA). RT reaction products from the exosome sample were further amplified using the Megaplex PreAmp Primers (Primers A v2.1).","9606","n/a","n/a","test","ath-miR-159 were used as a control. QRT-PCR was carried out on an Applied Biosystems 7900HT thermal cycler using the manufacturer’s recommended program.","All the raw data from each array was retrieved from the 7900HT and was run on Data Assist Software ver.3.1 (Applied Biosystems).","Fold Change worksheet reports test/control ratios.","GPL13987","Tomohiro,,Umezu","t_umezu@tokyo-med.ac.jp","+81-3-3342-6111","Department of Molecular Science","Tokyo Medical University","6-7-1 Nishi-shinjyuku","Shinjyuku","Tokyo","160-0023","Japan","NONE","384","BMSC","elderly donors (age of donor: 72 years)"
"GSM2079807","MM_MSC_1 exosome","GSM2079807","Public on May 12 2017","Mar 03 2016","May 12 2017","RNA","1","exosome","Homo sapiens","donor age: myeloma patient (age of donor: 62 years)","cell type: BMSC","The exosomes from culture medium of BMSCs were isolated by Total Exosome Isolation Reagent (Invitrogen).","BMSCs were cultured in DMEM medium supplemented with 10% heat-inactivated fetal bovine serum at 37°C in a humidified atmosphere containing 5% CO2, and the adherent cells were collected after two or three passages for exosome isolation.","total RNA","Total RNA was isolated with the miRNeasy mini kit (Qiagen).","TaqMan probe (FAM-MGB)","A fixed volume of 3 μl of RNA solution from 50 μl of the elute was used as input in each reverse transcription (RT) reaction. An RT reaction and pre-amplification step were set up according to manufacturers’ recommendations. miRNAs were reverse transcribed using the Megaplex Primer Pools (Human Pools A v2.1) from Applied Biosystems (Bedford, MA, USA). RT reaction products from the exosome sample were further amplified using the Megaplex PreAmp Primers (Primers A v2.1).","9606","n/a","n/a","test","ath-miR-159 were used as a control. QRT-PCR was carried out on an Applied Biosystems 7900HT thermal cycler using the manufacturer’s recommended program.","All the raw data from each array was retrieved from the 7900HT and was run on Data Assist Software ver.3.1 (Applied Biosystems).","Fold Change worksheet reports test/control ratios.","GPL13987","Tomohiro,,Umezu","t_umezu@tokyo-med.ac.jp","+81-3-3342-6111","Department of Molecular Science","Tokyo Medical University","6-7-1 Nishi-shinjyuku","Shinjyuku","Tokyo","160-0023","Japan","NONE","384","BMSC","myeloma patient (age of donor: 62 years)"
"GSM2079808","MM_MSC_2 exosome","GSM2079808","Public on May 12 2017","Mar 03 2016","May 12 2017","RNA","1","exosome","Homo sapiens","donor age: myeloma patient (age of donor: 77 years)","cell type: BMSC","The exosomes from culture medium of BMSCs were isolated by Total Exosome Isolation Reagent (Invitrogen).","BMSCs were cultured in DMEM medium supplemented with 10% heat-inactivated fetal bovine serum at 37°C in a humidified atmosphere containing 5% CO2, and the adherent cells were collected after two or three passages for exosome isolation.","total RNA","Total RNA was isolated with the miRNeasy mini kit (Qiagen).","TaqMan probe (FAM-MGB)","A fixed volume of 3 μl of RNA solution from 50 μl of the elute was used as input in each reverse transcription (RT) reaction. An RT reaction and pre-amplification step were set up according to manufacturers’ recommendations. miRNAs were reverse transcribed using the Megaplex Primer Pools (Human Pools A v2.1) from Applied Biosystems (Bedford, MA, USA). RT reaction products from the exosome sample were further amplified using the Megaplex PreAmp Primers (Primers A v2.1).","9606","n/a","n/a","test","ath-miR-159 were used as a control. QRT-PCR was carried out on an Applied Biosystems 7900HT thermal cycler using the manufacturer’s recommended program.","All the raw data from each array was retrieved from the 7900HT and was run on Data Assist Software ver.3.1 (Applied Biosystems).","Fold Change worksheet reports test/control ratios.","GPL13987","Tomohiro,,Umezu","t_umezu@tokyo-med.ac.jp","+81-3-3342-6111","Department of Molecular Science","Tokyo Medical University","6-7-1 Nishi-shinjyuku","Shinjyuku","Tokyo","160-0023","Japan","NONE","384","BMSC","myeloma patient (age of donor: 77 years)"
